Skip to main content
SpringerLink
Log in

Interaction of Citrus Juices with Cyclosporine: Systematic Review and Meta-Analysis

  • Systematic Review
  • Published:
European Journal of Drug Metabolism and Pharmacokinetics Aims and scope Submit manuscript

Abstract

Introduction

Cyclosporine is an immunosuppressant with narrow therapeutic window, metabolized mainly by cytochrome P450 3A4 (CYP3A4) and minimally by cytochrome P450 3A5 (CYP3A5). Citrus juices such as grapefruit juice (GFJ), orange, lemon, pomelo and lime were known to interact with cyclosporine in several randomized controlled trials. The present review is a systematic compilation and quantitative synthesis on the changes of cyclosporine pharmacokinetics with concomitant citrus juice administration.

Methods

Electronic databases were searched for randomized controlled trials evaluating the effect of any citrus juice on the pharmacokinetics of cyclosporine comparing with water or placebo in healthy volunteers using appropriate search strategies. Percent mean difference with standard error was used to assess the magnitude of difference in the following outcome measures: area under curve from time of drug administration to 24 h (AUC0–24), area under curve from time of drug administration to infinity (AUC0–∞), maximum concentration (C max), time to achieve C max (T max), elimination half-life (T 1/2), clearance (CL), volume of distribution and frequency for adverse drug reactions following administration of cyclosporine. RevMan 5.3 software was used to assess heterogeneity (by I2 statistics), use random-effects model and generate pooled results and Forest plot.

Results

A total of 57 studies were obtained with the search strategy, of which seven were found eligible to be included in the present review. The pooled percent mean difference [95 % CI] for GFJ in comparison to controls for AUC0-24, AUC0-∞, C max and T max of cyclosporine was observed to be 53 [43, 64], 53 [45, 62], 24 [12, 36] and 19 [12, 26], respectively. Similarly, pomelo juice was found to significantly increase both AUC0–∞ and C max with the pooled percent mean difference [95 % CI] as 23 [13, 32] and 25 [1, 50], respectively but decrease T 1/2 {−8 [−15, –1]} of cyclosporine. Orange juice did not alter any of the pharmacokinetic parameter of cyclosporine significantly.

Conclusion

Citrus juices especially GFJ and pomelo juice were found to significantly increase the plasma exposure of cyclosporine while orange juice did not exhibit any significant interaction with cyclosporine.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

References

  1. Tedesco D, Haragsim L. Cyclosporine: a review. J Transplant. 2012;2012:1. doi:10.1155/2012/230386.

    Article  Google Scholar 

  2. Traynor C, Jenkinson A, Williams Y, O’Kelly P, Hickey D, Denton M, Magee C, Conlon PJ. Twenty-year survivors of kidney transplantation. Am J Transplant. 2012;. doi:10.1111/j.1600-6143.2012.04236.x.

    PubMed  Google Scholar 

  3. Garcia SC, Lopes Luciana dos S, Schott KL, Beck ST, Pomblum VJ. Cyclosporine A and tacrolimus: a review. J Bras Patol Med Lab. 2004;40:393–401.

    Article  CAS  Google Scholar 

  4. Rang HP, Dale MM, Ritter JM, Flower RJ. Anti-inflammatory and immunosuppressant drugs, In Rang and Dale’s Pharmacology, 2007, Churchill Livingstone Elsevier, pp 242–43.

  5. Vari CE, Tero-Vescan A, Imre S, Muntean DL. Therapeutic drug monitoring of cyclosporine in transplanted patients. Possibilities, controversy, causes for failure. Farmacia. 2012;60:595–601.

    CAS  Google Scholar 

  6. Ekberg H, Bernasconi C, Nöldeke J, Yussim A, Mjörnstedt L, Erken U. Cyclosporine, tacrolimus and sirolimus retain their distinct toxicity profiles despite low doses in the Symphony study. Nephrol Dial Transplantm. 2010;25:2004–10.

    Article  CAS  Google Scholar 

  7. Billaud EM. C2 versus C0 cyclosporine monitoring: still not the end. Transplantation. 2005;80:542.

    Article  PubMed  Google Scholar 

  8. Knight SR, Morris PJ. The clinical benefits of cyclosporine C2-level monitoring: a systematic review. Transplantation. 2007;83:1525–35.

    Article  CAS  PubMed  Google Scholar 

  9. Sommerer C, Giese T, Meuer S, Zeier M. Pharmacodynamic monitoring of calcinuerin inhibitor therapy: is there a clinical benefit? Nephrol Dial Transplant. 2009;24:21–7.

    Article  CAS  PubMed  Google Scholar 

  10. Rodriguez-Fragoso L, Reyes-Esparza J. Fruit/vegetable-drug interactions: Effects on drug metabolizing enzymes and drug transporters. Available at: http://cdn.intechopen.com/pdfs-wm/41523.pdf (Accessed on 19 Apr 16).

  11. Kimmons J, Gillespie C, Seymour J, Serdula M, Blanck HM. Fruit and vegetable intake among adolescents and adults in the United States: percentage meeting individualized recommendations. Medscape J Med. 2009;11:26.

    PubMed  PubMed Central  Google Scholar 

  12. US Department of Agriculture, Agricultural Research Service, Food Surveys Research Group. Beltsville, MD: Composition of foods, raw, processed, Prepared USDA National Nutrient Database for Standard Reference, Release 25. http://www.ars.usda.gov/Services/docs.htm?docid=8964 [cited 20 Apr 2016].

  13. Murphy MM, Barraj LM, Rampersaud GC. Consumption of grapefruit is associated with higher nutrient intakes and diet quality among adults, and more favorable anthropometrics in women, NHANES 2003–2008. Food and Nutrition Research. 2014;58. doi:10.3402/fnr.v58.22179.

  14. Sterling ES, Smith KM. What’s the scoop with grapefruit? Orthopedics. 2005;28:31–4.

    PubMed  Google Scholar 

  15. Huang S-M, Lesko LJ. Drug-drug, drug-dietary supplement, and drug-citrus fruit and other food interactions: what have we learned? J Clin Pharmacol. 2004;44:559–69.

    Article  CAS  PubMed  Google Scholar 

  16. Malhotra S, Bailey DG, Paine MF, Watkins PB. Seville orange juice–felodipine interaction: comparison with dilute grapefruit juice and involvement of furocoumarins. Clin Pharmacol Ther. 2001;69:14–23.

    Article  CAS  PubMed  Google Scholar 

  17. Hou YC, Hsiu SL, Tsao CW, Wang YH, Chao PD. Acute intoxication of cyclosporin caused by coadministration of decoctions of the fruits of Citrus aurantium and the Pericarps of Citrus grandis. Planta Med. 2000;66:653–5.

    Article  CAS  PubMed  Google Scholar 

  18. Sermsappasuk P, Chaiyakunapruk N, Lohitnavy M, Kitiyakara C. Assessing clinical evidence of drug interactions between citrus juices and cyclosporine. Asian Biomed. 2013;7:477–89.

    CAS  Google Scholar 

  19. Center for Reviews and Dissemination. Available at: http://www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD42016037491 (Accessed on 11 Apr 2016).

  20. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions. 5.1.0 edition. Available from http://www.cochrane-handbook.org (Accessed on 15 Apr 2016).

  21. Moher D, Liberati A, Tetzlaff J, Altman DG. The PRISMA Group. preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol. 2009;62:1006–12.

    Article  PubMed  Google Scholar 

  22. Yee GC, Stanley DL, Pessa LJ, Costa TD, Beltz SE, Ruiz J, Lowenthal DT. Effect of grapefruit juice on blood cyclosporine concentration. Lancet. 1995;345:955–6.

    Article  CAS  PubMed  Google Scholar 

  23. Ku Y-M, Min DI, Flanigan M. Effect of grapefruit juice on the pharmacokinetics of microemulsion cyclosporine and its metabolite in healthy volunteers: does the formulation difference matter? J Clin Pharmacol. 1998;38:959–65.

    Article  CAS  PubMed  Google Scholar 

  24. Edwards DJ, Fitzsimmons ME, Schuetz EG, Yasuda K, Ducharme MP, Warbasse LH, Woster PM, Schuetz JD, Watkins P. 6′, 7′-Dihydroxybergamottin in grapefruit juice and Seville orange juice: effects on cyclosporine disposition, enterocyte CYP3A4, and P-glycoprotein. Clin Pharmacol Ther. 1999;65:237–44.

    Article  CAS  PubMed  Google Scholar 

  25. Schwarz UI, Johnston PE, Bailey DG, Kim RB, Mayo G, Milstone A. Impact of citrus soft drinks relative to grapefruit juice on ciclosporin disposition. Br J Clin Pharmacol. 2005;62:485–91.

    Article  PubMed Central  Google Scholar 

  26. Lee M, Min DI, Ku Y-M, Flanigan M. Effect of grapefruit juice on pharmacokinetics of microemulsion cyclosporine in African American subjects compared with Caucasian subjects: does ethnic difference matter? J Clin Pharmacol. 2001;41:317–23.

    Article  PubMed  Google Scholar 

  27. Anlamlert W, Sermsappasuk P, Yokubol D, Jones S. Pomelo enhances cyclosporine bioavailability in healthy male Thai volunteers. J Clin Pharmacol. 2015;55:377–83.

    Article  CAS  PubMed  Google Scholar 

  28. Grenier J, Fradette C, Morelli G, Merritt GJ, Vranderick M, Ducharme MP. Pomelo juice, but not cranberry juice, affects the pharmacokinetics of cyclosporine in humans. Clin Pharmacol Ther. 2006;79:255–62.

    Article  CAS  PubMed  Google Scholar 

  29. Smiciklas-Wright H, Mitchell DC, Mickle SJ, Cook AJ, Goldman JD. US Government Printing Office; Foods commonly eaten in the United States: quantities consumed per eating occasion and in a day, 1994–96. http://www.ars.usda.gov/SP2UserFiles/Place/12355000/pdf/Portion.pdf [cited 20 Apr 2016].

  30. Miniscalco A, Lundahl J, Regardh CG, Edgar B, Eriksson UG. Inhibition of dihydropyrimidine metabolism in rat and human liver microsomes by flavonoids found in grapefruit juice. J Pharmacol Exp Ther. 1992;261:1195–9.

    CAS  PubMed  Google Scholar 

  31. Lown KS, Mayo RR, Leichtman AB, Hsiao HL, Turgeon DK, Schmiedlin-Ren P, Brown MB, Guo W, Rossi SJ, Benet LZ, Watkins PB. Role of intestinal P-glycoprotein (mdr1) in interpatient variation in the oral bioavailability of cyclosporine. Clin Pharmacol Ther. 1997;62:248–60.

    Article  CAS  PubMed  Google Scholar 

  32. Kakar SM, Paine MF, Stewart PW, Watkins PB. 6′7′ Dihydroxybergamottin contributes to the grapefruit juice effect. Clin Pharmacol Ther. 2004;75:569–79.

    Article  CAS  PubMed  Google Scholar 

  33. Fukuda K, Guo L, Ohashi N, Yoshikawa M, Yamazoe Y. Amounts and variation in grapefruit juice of the main components causing grapefruit-drug interaction. J Chromatogr B Biomed Sci Appl. 2000;741:195–203.

    Article  CAS  PubMed  Google Scholar 

  34. Saito M, Hirata-Koizumi M, Matsumoto M, Urano T, Hasegawa R. Undesirable effects of citrus juice on the pharmacokinetics of drugs: focus on recent studies. Drug Saf. 2005;28:677–94.

    Article  CAS  PubMed  Google Scholar 

  35. Dahan A, Altman H. Food-drug interaction: grapefruit juice augments drug bioavailability—mechanism, extent and relevance. Eur J Clin Nutr. 2004;58:1–9.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We thank PROSPERO for registering this review and Cochrane for using RevMan software to generate Forest plot and pooled analysis.

Author information

Authors and Affiliations

  1. Pharmacology, Department of Health Sciences, Fiji National University, Suva, Fiji

    Kannan Sridharan

  2. Prosthodontics, Department of Oral Health, Fiji National University, Suva, Fiji

    Gowri Sivaramakrishnan

Authors
  1. Kannan Sridharan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gowri Sivaramakrishnan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kannan Sridharan.

Ethics declarations

Conflict of Interest

KS and GS have no conflict of interest.

Funding

No funding was obtained for conducting this review and meta-analysis.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sridharan, K., Sivaramakrishnan, G. Interaction of Citrus Juices with Cyclosporine: Systematic Review and Meta-Analysis. Eur J Drug Metab Pharmacokinet 41, 665–673 (2016). https://doi.org/10.1007/s13318-016-0351-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13318-016-0351-4

Keywords

Search

Navigation